Improved Survival, Vascular Differentiation and Wound Healing Potential of Stem Cells Co-Cultured with Endothelial Cells
2011

Improved Healing of Diabetic Wounds with Stem Cells and Endothelial Cells

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Pedroso Dora C. S., Tellechea Ana, Moura Liane, Fidalgo-Carvalho Isabel, Duarte João, Carvalho Eugénia, Ferreira Lino

Primary Institution: Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal

Hypothesis

Can co-culturing umbilical cord blood-derived hematopoietic stem cells with endothelial cells improve their survival and regenerative potential for healing diabetic wounds?

Conclusion

Co-culturing umbilical cord blood-derived stem cells with endothelial cells significantly enhances wound healing in diabetic mice.

Supporting Evidence

  • CD34+-derived endothelial cells improved the survival of CD34+ cells in co-culture.
  • Co-cultured cells showed enhanced differentiation into endothelial cells.
  • Wound healing was significantly better in diabetic mice treated with the co-culture compared to controls.
  • Inflammatory markers were reduced in wounds treated with the co-culture.
  • CD34+-derived endothelial cells secreted cytokines that promoted cell survival.
  • Fibrin gels provided a supportive environment for cell adhesion and growth.
  • Co-culture led to increased neovascularization in the wound area.
  • Significant differences in wound closure rates were observed at day 3 post-treatment.

Takeaway

This study shows that mixing special blood cells from umbilical cords with other cells helps heal wounds better, especially for people with diabetes.

Methodology

The study involved isolating CD34+ cells from umbilical cord blood and co-culturing them with endothelial cells in a fibrin gel, followed by testing in a diabetic mouse model.

Potential Biases

Potential bias due to the small sample size and the specific animal model used.

Limitations

The study's findings may not be directly applicable to human patients due to differences in immune response and healing processes.

Participant Demographics

Diabetic male C57BL/6 mice aged 10-12 weeks were used for the in vivo experiments.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016114

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication